Steve W. Berman, Managing Partner
Steve Berman co-founded Hagens Berman in 1993 and is the firm’s managing partner. He represents consumers, investors and employees in large, complex litigation held in state and federal courts. Berman’s trial experience has earned him significant recognition and led The National Law Journal to name him one of the 100 most powerful lawyers in the nation, and to repeatedly name Hagens Berman one of the top 10 plaintiffs’ firms in the country. Berman was inspired to build a firm that vociferously fought for the rights of those unable to fight for themselves. His innovative approach, tenacious conviction and impeccable track record have earned him an excellent reputation and numerous historic legal victories. He is considered one of the nation’s most successful class-action attorneys.
Steve Berman was lead counsel for 13 states in cases that led to the largest settlement in world history against Big Tobacco and has represented numerous other states and governments in litigation involving product defects, drug pricing and other issues affecting consumers across the nation. In McKesson Governmental Entity Litigation, he was lead counsel for a nationwide class of local governments that resulted in an $82 million settlement for drug price-fixing claims. He also served as outside counsel for the state of New York for its Vioxx claims, several states for AWP claims and several states for claims against McKesson in State and Governmental Drug Litigation. Opioid abuse is one of our nation’s leading health disasters. Steve is leading the first litigation seeking to recover public costs resulting from the opioid manufacturer’s deceptive marketing on behalf of California's Orange and Santa Clara counties. In addition, Steve is assisting the Arizona Attorney General in its law enforcement action versus General Motors Co. related to In re: General Motors LLC Ignition Switch Litigation. more »
Thomas M. Sobol, Partner & Executive Committee Member
Tom Sobol is a member of Hagens Berman's executive committee and leads the firm's Boston office, where he spearheads the firm's drug pricing litigation efforts against numerous pharmaceutical and medical device companies. Mr. Sobol was voted one of 10 leading litigators in Massachusetts and has been involved in some of Hagens Berman's most prominent victories. Mr. Sobol's noteworthy cases include: Neurontin class action marketing settlement ($325 million), NECC meningitis outbreak settlement ($200 million), Flonase direct purchaser litigation settlement ($150 million), Wellbutrin XL direct purchaser litigation ($37.5 million), First Databank litigation (4% price reduction of most retail drugs), McKesson litigation ($350 million), Vioxx third party payor litigation ($80 million), Paxil direct purchaser litigation ($150 million) and Co-lead trial counsel in the Neurontin MDL ($142 million RICO jury verdict).
He also recovered $25 Million for the state of Connecticut for Zyprexa fraud. Hagens Berman served as outside counsel to Attorney General Richard Blumenthal in the litigation that alleged Lilly engaged in unlawful off-label promotion of the atypical antipsychotic Zyprexa and made significant misrepresentations about Zyprexa’s safety and efficacy, resulting in millions of dollars in excess pharmaceutical costs borne by the State and its taxpayers. State of Connecticut v. Eli Lilly & Co., E.D.N.Y., Civil Action No. 08-cv-955-JBW. Mr. Sobol has also served as special Assistant Attorney General for the Commonwealth of Massachusetts and the states of New Hampshire and Rhode Island. more »
